Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3711170018 | Acetaminophen- and phenyltoloxamine- and salicylamide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3711171019 | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3711172014 | Product containing paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Has active ingredient | Phenyltoloxamine (substance) | true | Inferred relationship | Some | 2 | |
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Is a | Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product) | true | Inferred relationship | Some | ||
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Has active ingredient | Paracetamol | true | Inferred relationship | Some | 3 | |
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Is a | Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Has active ingredient | Salicylamide | true | Inferred relationship | Some | 1 | |
Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Is a | Paracetamol- and salicylamide-containing product in oral dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) | Is a | False | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Inferred relationship | Some | |
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet | Is a | False | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Inferred relationship | Some | |
Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) | Is a | True | Paracetamol- and phenyltoloxamine- and salicylamide-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets